2027 Healthcare Professional Patients Provider 
GeriPal
APRIL 3, 2025
That was actually Ken, you remember that article, Nancy Schoenberg’s article on screening and what to say and what not to say to patients on how to talk. How to talk to patients about screening colonoscopies. So therefore I feel that I am obligated to tell patients about this option. Ken 09:56 We did a role play.
FDA Law Blog
FEBRUARY 11, 2024
The three letters together provide the range of actions DEA may take: no rescheduling from schedule I (former drug officials), rescheduling to schedule III (Democratic state attorneys general), or descheduling altogether (Democratic senators). Letter 1 is signed by former DEA administrators and Directors of National Drug Policy.
Expert insights. Personalized for you.
64 
Let's personalize your content